• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Oncology

Cancer screening costs in the United States may exceed $40 billion annually

byJayden Berdugo, MDandThomas Su
August 14, 2024
in Oncology, Public Health
Reading Time: 3 mins read
Colonoscopy collage: a woman beside a drawing of the large intestine, a coiled flexible scope and a glass of clear liquid
Share on FacebookShare on TwitterShare on LinkedIn

1. In the United States, the estimated annual cost of cancer screening was $43 billion, with private insurance covering the majority of spending.

2. Colorectal cancer screening was the most frequently performed test and comprised nearly two-thirds of total spending.

Evidence Rating Level: 2 (Good)

Study Rundown: Cancer continues to be one of the greatest sources of morbidity and mortality worldwide, with over 600,000 deaths projected in the United States alone in 2024. Public interventions such as the U.S. government’s Cancer Moonshot initiative have contributed to lower mortality rates in recent years. Particularly significant gains have been made in cancers for which population-wide screening is currently recommended, including breast, cervical, colorectal, and lung. While prior studies have described the costs and effectiveness of screening for specific cancers or among specific populations, the overall scale of healthcare expenditure toward this goal remains unclear. This study combined National Health Interview Survey responses with public and private insurance cost estimates to generate a model of comprehensive spending for recommended cancer screening in 2021. Overall, the United States was found to have spent over $43 billion on initial cancer screening during this period, which was still less than the reported cost of cancer treatment in the first 12 months following diagnosis. Colonoscopy alone accounted for over half of total spending, with breast and cervical cancer screenings accounting for a further one-third. Facility costs were found to be substantially greater than physician costs, representing a potential opportunity for intervention. Limitations of this study include self-reporting bias due to reliance on surveys, as well as lack of analysis on the costs of follow-up procedures. Nonetheless, this study provided new estimates for the annual cost of cancer screening in the United States.

Click to read the study in the Annals of Internal Medicine

Relevant Reading: Screening for cancer: the economic, medical and psychosocial issues

RELATED REPORTS

American Cancer Society recommends regular PSA-based screening for men at average and higher risk

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

In-Depth [survey]: This study utilized self-reported data from 2021 National Health Interview Survey. Breast, cervical, colorectal, lung, and prostate cancer screening tests were selected for inclusion based on the strength of recommendation by the U.S. Preventive Services Task Force. Overall, the United States spent $43.2 billion on initial cancer screenings in 2021, with 88.3% stemming from private insurance, 8.5% from Medicare, and 3.2% from Medicaid and other government programs. Mammography and cervical cancer screenings were the two most frequently performed tests, but colorectal cancer screening dominated spending at 63.6% of the total. The overall cost percentages for breast, cervical, lung, and prostate cancer screening were 20.4%, 12.8%, 1.5% and 1.6%, respectively. Some variation in usage patterns was noted; for instance, among the Medicaid and uninsured population, colonoscopy accounted for 37.2% of total costs whereas breast and cervical cancer occupied greater shares at 26.9% and 13.8%, respectively. Notably, the cost for each screening test was higher for those with private insurance as compared to those with Medicare (357%) and Medicaid or other government programs (519%). In sensitivity analyses, it was found that just reducing facility costs by 20% would generate a net savings of $3.3 billion, with a greater proportion of this benefit affecting those with government insurance or no insurance as compared to those with private insurance. These findings aid in the identification of costs and cost drivers for cancer screening in the United States.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancer screeningdisparitieshealthcare costsinsurance
Previous Post

#VisualAbstract: Atezolizumab and Chemotherapy Improve Outcomes in Advanced or Recurrent Endometrial Cancer

Next Post

No evidence of reliable biomarkers of postacute sequelae of SARS-CoV-2

RelatedReports

Collage on the PSA blood test: an engraved bladder and prostate, a capped blood tube, a balance scale and a blank calendar
2MM Trial Briefs

American Cancer Society recommends regular PSA-based screening for men at average and higher risk

November 12, 2026
A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.
All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026
Lung cancer screening collage: a smiling white-haired man beside engraved lungs with a magnifying glass over the upper lobe
Oncology

Lung cancer screening models show variable performance across populations

June 29, 2026
Whole-body MRI collage: an MRI scanner with an empty table, an orange carpet runner and a vintage press camera on a tripod
Imaging and Intervention

Celebrity body scans are colliding with radiology evidence

September 4, 2026
Next Post

No evidence of reliable biomarkers of postacute sequelae of SARS-CoV-2

Walking for health collage: a pair of walking shoes and a fitness band at the start of a winding path toward a tree

Individualized walking and education program reduces the recurrence of low back pain

Perturbation-based balance training of older adults and effects on physiological, cognitive and sociopsychological factors

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
  • A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.